Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanosecond pulsed electric field ablation-induced modulation of sphingolipid metabolism is associated with Ly6c2+ mononuclear phagocyte differentiation in liver cancer. | Mol Oncol | 2023 | 36587393 | PubTator, text mining | PubMed |
| Color-biased regions in the ventral visual pathway are food selective. | Curr Biol | 2023 | 36574774 | PubTator, text mining | PubMed |
| Improved Assembly of Metagenome-Assembled Genomes and Viruses in Tibetan Saline Lake Sediment by HiFi Metagenomic Sequencing. | Microbiol Spectr | 2023 | 36475839 | PubTator, text mining | PubMed |
| Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia: a retrospective study. | Pediatr Nephrol | 2023 | 36409364 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL. | EMBO Rep | 2023 | 36408842 | PubTator, text mining | PubMed |
| LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma. | Transl Oncol | 2023 | 36401967 | PubTator, text mining | PubMed |
| Bacterial extracellular vesicle applications in cancer immunotherapy. | Bioact Mater | 2023 | 36382022 | PubTator, text mining | PubMed |
| An ERAD-independent role for rhomboid pseudoprotease Dfm1 in mediating sphingolipid homeostasis. | EMBO J | 2023 | 36350249 | PubTator, text mining | PubMed |
| Oxalate homeostasis. | Nat Rev Nephrol | 2023 | 36329260 | PubTator, text mining | PubMed |
| Intramuscular administration of glyoxylate rescues swine from lethal cyanide poisoning and ameliorates the biochemical sequalae of cyanide intoxication. | Toxicol Sci | 2023 | 36326479 | PubTator, text mining | PubMed |
| A case report of invasive infantile primary hyperoxaluria type 1 and literature review. | CEN Case Rep | 2023 | 36194362 | PubTator, text mining | PubMed |
| Primary hyperoxaluria: Comprehensive mutation screening of the disease causing genes and spectrum of disease-associated pathogenic variants. | Clin Genet | 2023 | 36185032 | PubTator, text mining | PubMed |
| Lipid-based nucleic acid therapeutics with in vivo efficacy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2023 | 36180107 | PubTator, text mining | PubMed |
| Exacerbation-prone pediatric asthma is associated with arginine, lysine, and methionine pathway alterations. | J Allergy Clin Immunol | 2023 | 36096204 | PubTator, text mining | PubMed |
| Combination of Peglated-H1/HGFK1 Nanoparticles and TAE in the Treatment of Hepatocellular Carcinoma. | Appl Biochem Biotechnol | 2023 | 36094649 | PubTator, text mining | PubMed |
| Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1? | J Nephrol | 2023 | 35986861 | PubTator, text mining | PubMed |
| Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling. | J Adv Res | 2023 | 35973552 | PubTator, text mining | PubMed |
| Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. | Pediatr Nephrol | 2023 | 35913563 | PubTator, text mining | PubMed |
| Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure. | Cardiovasc Res | 2023 | 35815623 | PubTator, text mining | PubMed |
| Genetic assessment in primary hyperoxaluria: why it matters. | Pediatr Nephrol | 2023 | 35695965 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=28